文献速递神经肿瘤

对比增强斑点作为胶质瘤患者迟发性假性进展的新模式

Contrast enhancing spots as a new pattern of late onset pseudoprogression in glioma patients.
PubMed 文献 · J Neurooncol · 2019-01-02

研究前瞻性收集2014至2016年26例新发对比增强斑点(NCES)的23例胶质瘤患者,回顾分析显示NCES多发生于诊断后中位52个月、末次放疗后中位30个月,多数可自发消退或稳定,仅4例演变为肿瘤复发,作者推测其可能代表放疗诱导的血管病变。

要点

  • 迟发性NCES多发生于年轻、IDH突变型胶质瘤患者,中位出现于放疗后30个月。
  • 多数NCES可自发消退(中位10个月)或稳定(中位随访26个月),仅4例演变为肿瘤复发。
  • 作者认为迟发性NCES可能代表放疗诱导的血管病变,启动新治疗前需考虑此现象。

核心结论

  • 作者推测迟发性新发对比增强斑点(NCES)主要代表一种不同于早期假性进展的放疗诱导的血管病变,尤其在年轻IDH突变型胶质瘤患者启动新治疗前应考虑此现象。

研究设计与样本

  • 前瞻性收集2014至2016年每周肿瘤委员会中23例胶质瘤患者的26次NCES事件(3例患者各有两次独立NCES事件),未按诊断、分子标志物或 pretreatment 进一步筛选,随后进行回顾性分析。

主要发现

  • NCES患者中位年龄49岁,IDH突变型胶质瘤占61%,初始组织学为胶质母细胞瘤26%、III级52%、II级22%。
  • NCES出现于肿瘤诊断后中位52个月、末次放疗后中位30个月。
  • 多数NCES自发消退(n=11,中位10个月)或未经进一步治疗保持稳定(n=7,中位随访26个月)。
  • 仅4次NCES在MRI形态学上演变为肿瘤复发;2次NCES被切除但组织病理学无肿瘤复发证据;另2例NCES分别定义为缺血性卒中或放射性坏死。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Magnet resonance imaging (MRI) of gliomas is assessed by Response Assessment in Neuro-Oncology Criteria (RANO), which define new contrast-enhancing lesions as a sign for tumor recurrence. Pseudoprogression after radiotherapy may mimic tumor progression in MRI but is usually limited to the first months after irradiation. We noted a late onset pattern of new contrast-enhancing spots (NCES) appearing years after radiotherapy. METHODS: We prospectively collected 23 glioma patients with 26 NCES (three patients had two separate NCES events) between 2014 and 2016 in our weekly tumor board without further selection by diagnosis, molecular markers or pretreatment. RESULTS: Retrospective analysis revealed a homogeneous collective of young patients (median age of 49 years at NCES) with mainly IDH-mutated glioma (61%). Initial histology showed 26% glioblastoma, 52% grade III and 22% grade II glioma. NCES occurred at late follow-up with a median of 52 months after tumor diagnosis and 30 months after the last radiotherapy. The majority of NCES regressed spontaneously within a median of 10 months (n = 11) or remained stable without further therapy with a median follow-up of 26 months (n = 7). Only 4 NCES developed MRI morphologically into tumor recurrence. Two NCES were resected without any histopathological proof of tumor recurrence, and in 2 other cases NCES were defined as ischemic stroke or radionecrosis. CONCLUSION: We hypothesize that the late onset phenomenon of NCES predominantly represents a form of radiation-induced vasculopathy that is different from early pseudoprogression and should be considered especially in younger patients with IDH-mutated glioma before initiation of new therapy.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Voss M, Franz K, Steinbach JP, et al. Contrast enhancing spots as a new pattern of late onset pseudoprogression in glioma patients. J Neurooncol. 2019. PMID: 30604393. doi:10.1007/s11060-018-03076-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。